BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
NXDT
NexPoint Diversified Real Estate Trust
There isn't enough reported data to score NXDT yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
NXDT Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| N/A | |
| N/A |
NXDT's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like NXDT.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
NXDT PE Valuation
NXDT has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
NXDT Forward outlook
There aren't enough analyst estimates for NXDT to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over NXDT on earnings quality, reporting a profit while its opponent remains loss making.
NXDT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.48 | +$0.76 |
| Q1 2026 | -$2.47 | -$0.98 |
| Q4 2025 | -$2.81 | -$1.53 |
| Q3 2025 | -$2.28 | -$0.76 |
| Q2 2025 | -$2.24 | +$0.89 |
| Q1 2025 | -$1.49 | +$1.80 |
| Q4 2024 | -$1.28 | +$1.98 |
NXDT is still losing money, but far less than before: $1.48 per share over the past year, against $3.29 at its worst in early 2024.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over NXDT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over NXDT on profitability, with a higher operating margin.
NXDT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $19.3M | -8.1% |
| Q1 2026 | $22.9M | -21% |
| Q4 2025 | $18.4M | -29% |
| Q3 2025 | $17.5M | -21% |
| Q2 2025 | $21M | -5.6% |
| Q1 2025 | $29.1M | +127% |
| Q4 2024 | $25.9M | +17% |
| Q3 2024 | $22.2M | +80% |
NXDT's revenue has slid since its 2022 peak: $19M last quarter, down 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 11% | +12 points |
| Q1 2026 | 15% | -3.9 points |
| Q4 2025 | -19% | -22 points |
| Q3 2025 | -19% | +7.7 points |
| Q2 2025 | -0.6% | -3.3 points |
| Q1 2025 | 19% | +17 points |
| Q4 2024 | 3.6% | -40 points |
| Q3 2024 | -27% | -23 points |
NXDT's operating margin was 11% last quarter, up 12 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over NXDT on cash generation, producing positive trailing cash flow while its opponent burns cash.
NXDT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$4.6M | -6277% |
| Q1 2026 | -$498K | -107% |
| Q4 2025 | $1.2M | +$5.3M |
| Q3 2025 | $835K | +68% |
| Q2 2025 | $75K | +$5.6M |
| Q1 2025 | $7.1M | +$9.6M |
| Q4 2024 | -$4.1M | +$1.7M |
| Q3 2024 | $497K | -79% |
NXDT's free cash flow was −$3M over the past year, against $4M the year before. Free cash flow isn't a meaningful measure for financial services companies like NXDT.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over NXDT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
NXDT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +21% | +10.4M shares |
| 1 year | +32% | +14.8M shares |
| 3 years | +63% | +23.3M shares |
NXDT has 60M diluted shares, up 32% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $515,000 |
| Q1 2026 | $2.3M |
| Q4 2025 | $1.1M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
NXDT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
| Q4 2025 | -0.5x | Net Cash |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | -0.8x | Net Cash |
| Q3 2024 | -0.5x | Net Cash |
NXDT has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
NXDT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.4 | Oversold |
| Stochastic | 5.6 | Oversold |
NXDT's weekly RSI is 29 (oversold) and its Stochastic is 6 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
NXDT PE vs Financial Services Sector
| Metric | NXDT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
NXDT has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has the edge over NXDT on trend strength, trading above more of its moving averages.
NXDT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.48 | 32% below |
| 20 week MA | $4.93 | 38% below |
| 50 week MA | $4.64 | 34% below |
| 100 week MA | $4.43 | 31% below |
| 200 week MA | $6.29 | 51% below |
NXDT is in a downtrend: it's below all five of its weekly moving averages, and 51% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over NXDT on returns for 2026, with the stronger performance.
NXDT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.8 | $10.5 | -41% |
| 2021 | $10.5 | $13.9 | +33% |
| 2022 | $13.9 | $11.8 | -15% |
| 2023 | $11.8 | $7.95 | -33% |
| 2024 | $7.95 | $6.37 | -20% |
| 2025 | $6.37 | $3.88 | -39% |
| 2026 YTD | $3.88 | $3.06 | -21% |
NXDT has finished four years in a row lower, and it's down 21% so far in 2026.